Latest Related Publications

The 2021 optimal formulary and limited-use list for antiretroviral drugs for children – WHO policy brief

On 26 April 2021, the World Health Organization (WHO) released its policy brief called “The 2021 optimal formulary and limited-use list for antiretroviral drugs for children – WHO policy brief”, with the endorsement and/or support from a number of key organisations, including the Medicines Patent Pool. Access the Policy Brief

30 April 2021